Magnasense AB (OSTO:MAGNA) EBIT per Share : kr-0.85 (TTM As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Magnasense AB EBIT per Share?

Magnasense AB's EBIT per Share for the three months ended in Dec. 2024 was kr-0.37. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 was kr-0.85.

During the past 3 years, the average EBIT per Share Growth Rate was 47.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Magnasense AB's EBIT per Share or its related term are showing as below:

OSTO:MAGNA' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -36.3 Med: 5.5 Max: 47.3
Current: 47.3

During the past 6 years, the highest 3-Year average EBIT per Share Growth Rate of Magnasense AB was 47.30% per year. The lowest was -36.30% per year. And the median was 5.50% per year.

OSTO:MAGNA's 3-Year EBIT Growth Rate is ranked better than
89.12% of 708 companies
in the Medical Devices & Instruments industry
Industry Median: 5.65 vs OSTO:MAGNA: 47.30

Magnasense AB's EBIT for the three months ended in Dec. 2024 was kr-21.38 Mil.

Magnasense AB EBIT per Share Historical Data

The historical data trend for Magnasense AB's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Magnasense AB EBIT per Share Chart

Magnasense AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT per Share

Get a 7-Day Free Trial

-0.89

-5.56

-16.64

-2.22

-0.71

Magnasense AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT per Share	Get a 7-Day Free Trial															-0.35	-0.10	-0.04	-0.34	-0.37

Magnasense AB EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Magnasense AB's EBIT per Share for the fiscal year that ended in Dec. 2024 is calculated as

	EBIT per Share		(A: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-43.922	/	62.339
=	-0.70

Magnasense AB's EBIT per Share for the quarter that ended in Dec. 2024 is calculated as

	EBIT per Share		(Q: Dec. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-21.376	/	57.217
=	-0.37

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-0.85

Magnasense AB (OSTO:MAGNA) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Magnasense AB EBIT per Share Related Terms

Thank you for viewing the detailed overview of Magnasense AB's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Magnasense AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Magnasense AB (OSTO:MAGNA) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

52Q:Germany

Address

Scheelevagen 27, Lund, SWE, SE-223 63

Website

https://www.aegirbio.com

AegirBio AB is a Swedish diagnostic company, specializes in developing a home testing platform for oral health, therapeutic drug monitoring and infectious diseases. The current product line up includes the Veritope technology, featuring intact natalizumab in MS, along with the MagniaReader designed for both research and veterinary applications.

Magnasense AB Headlines

No Headlines